JPRN-UMIN000015518已完成未知
Efficacy and safety of preoperative somatostatine analogue treatment in acromegaly - Efficacy and safety of preoperative somatostatine analogue treatment in acromegaly
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with severe infections, liver disease, kidney disease, etc. 2) Patient who cannot be performed the necessary examination for evaluation. 3) Patients who investigator deem inappropriate.
研究者
相似试验
进行中（未招募）
1 期
The effectiveness of Octreotide in hereditary hemorrhagic telangiectasia (a.k.a. Rendu-Osler-Weber disease) patients who suffer from gastrointestinal bleeding.EUCTR2018-004179-11-NLRadboudumc38
尚未招募
不适用
Onderzoek naar de effectiviteit van octreotide in hereditary hemorrhagic telangiectasia patiënten metdaarbij gastrointestinale bloedingen.NL-OMON25382Radboudumc38
进行中（未招募）
1 期
The effectiveness of Octreotide in hereditary hemorrhagic telangiectasia(a.k.a. Rendu-Osler-Weber disease) patients who suffer fromgastrointestinal bleeding.EUCTR2018-004179-11-DERadboudumc38
进行中（未招募）
1 期
Effectiveness of somatostatin analogues for GI bleeding in patients with hereditaryhemorrhagic telangiectasiaHereditary hemorrhagic telangiectasia (HHT), also known as Osler–Weber–Rendu disease(in specific patients with gastrointestinal bleeding and transfusion dependency)MedDRA version: 21.0Level: PTClassification code 10019883Term: Hereditary haemorrhagic telangiectasiaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2018-004179-11-ITRADBOUD UNIVERSITY MEDICAL CENTER38
进行中（未招募）
1 期
The effectiveness of Octreotide in hereditary hemorrhagic telangiectasia (a.k.a. Rendu-Osler-Weber disease) patients who suffer from gastrointestinal bleeding.EUCTR2018-004179-11-FRRadboudumc38